Next Article in Journal
Socioeconomic Drivers of PM2.5 in the Accumulation Phase of Air Pollution Episodes in the Yangtze River Delta of China
Previous Article in Journal
Menopausal Age and Chronic Diseases in Elderly Women: A Cross-Sectional Study in Northeast China
Article Menu

Export Article

Open AccessArticle
Int. J. Environ. Res. Public Health 2016, 13(10), 937;

Acetamiprid Accumulates in Different Amounts in Murine Brain Regions

Department of Anatomy, Division of Basic Medicine, Tokai University School of Medicine, Kanagawa 259-1193, Japan
Department of Community Health, Tokai University School of Medicine, Kanagawa 259-1193, Japan
Support Center for Medical Research and Education, Tokai University School of Medicine, Kanagawa 259-1193, Japan
Department of Anatomy, Aichi Medical University, Aichi 480-1195, Japan
Division of Oral and Craniofacial Anatomy, Graduate School of Dentistry, Tohoku University, Sendai 980-8575, Japan
Department of Human Development, Tokai University School of Humanities and Culture, Kanagawa 259-1292, Japan
Author to whom correspondence should be addressed.
Academic Editor: Paul B. Tchounwou
Received: 8 June 2016 / Revised: 12 September 2016 / Accepted: 15 September 2016 / Published: 22 September 2016
Full-Text   |   PDF [5673 KB, uploaded 22 September 2016]   |  


Neonicotinoids such as acetamiprid (ACE) belong to a new and widely used single class of pesticides. Neonicotinoids mimic the chemical structure of nicotine and share agonist activity with the nicotine acetylcholine receptor (nAchR). Neonicotinoids are widely considered to be safe in humans; however, they have recently been implicated in a number of human health disorders. A wide range of musculoskeletal and neuromuscular disorders associated with high doses of neonicotinoids administered to animals have also been reported. Consequently, we used a mouse model to investigate the response of the central nervous system to ACE treatment. Our results show that exposure to ACE-containing water for three or seven days (decuple and centuple of no observable adverse effect level (NOAEL)/day) caused a decrease in body weight in 10-week old A/JJmsSlc (A/J) mice. However, the treatments did not affect brain histology or expression of CD34. ACE concentrations were significantly higher in the midbrain of ACE-treated mice than that of the normal and vehicle groups. Expression levels of α7, α4, and β2 nAChRs were found to be low in the olfactory bulb and midbrain of normal mice. Furthermore, in the experimental group (centuple ACE-containing water for seven days), β2 nAChR expression decreased in many brain regions. Information regarding the amount of accumulated ACE and expression levels of the acetylcholine receptor in each region of the brain is important for understanding any clinical symptoms that may be associated with ACE exposure. View Full-Text
Keywords: acetamiprid; mouse; brain; concentration; neonicotinoid acetamiprid; mouse; brain; concentration; neonicotinoid

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Supplementary material


Share & Cite This Article

MDPI and ACS Style

Terayama, H.; Endo, H.; Tsukamoto, H.; Matsumoto, K.; Umezu, M.; Kanazawa, T.; Ito, M.; Sato, T.; Naito, M.; Kawakami, S.; Fujino, Y.; Tatemichi, M.; Sakabe, K. Acetamiprid Accumulates in Different Amounts in Murine Brain Regions. Int. J. Environ. Res. Public Health 2016, 13, 937.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Environ. Res. Public Health EISSN 1660-4601 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top